by MobileODT | Jan 14, 2019 | Blog
The National Cancer Institute released a groundbreaking new study demonstrating the ability of an AI algorithm to detect cervical cancer or precancer in seconds, from a single image of the cervix. The automated visual evaluation algorithm holds the promise to...
by MobileODT | Jan 11, 2019 | Press Releases
MobileODT, first to develop a commercial application for AVE machine learning algorithm for cervical cancer detection January 11, 2019 – Tel Aviv – A new augmented intelligence (AI) algorithm is able to detect cervical cancer based on a single image....
by Rachel Gross | Dec 3, 2018 | Blog
Sex workers experience numerous healthcare issues. Dr. Judy Norman discusses how to perform women’s health and colposcopy within this population.
by Rachel Gross | Nov 29, 2018 | Blog
Billions of dollars are spent every year in preventing and treating the HIV/AIDS epidemic. Antiretroviral treatments are prolonging life expectancy for people with HIV and giving new hope for the future. But a quiet tragedy is playing out for thousands of HIV+ women....
by Rachel Gross | Nov 5, 2018 | Blog
The 32rd International Papillomavirus Conference in Sydney was a whirlwind of new discoveries in the HPV world with the revelation of new cervical cancer screening AI by the National Cancer Institute and coinciding with the announcement of Australian vaccination...
by Mary Rubin, PhD | Oct 18, 2018 | Blog
Welcome back to our Colpo Corner, where we explore various aspects of colposcopy. In this edition Mary Rubin, PhD, WHNP-BC, FAANP shares her advice on performing colposcopy during pregnancy based on her 35 years of experience working in colposcopy. Performing...
by Rachel Gross | Oct 10, 2018 | Blog
‘Australia defeats cervical cancer’ was announced on newspaper headlines this week. Around the world, the initial results of the Australian government initiative to introduce HPV vaccination to high school age students suggested that cervical cancer instances may have...
by Mary Rubin, PhD | Sep 26, 2018 | Blog
Diethylstilbestrol (DES) was marketed to prevent miscarriage, premature labor and other pregnancy-related complications from 1940 to 1971. However, this synthetic form of estrogen caused significant birth defects, notably leaving children born to the mother who had...
by MobileODT | Aug 14, 2018 | Blog
Millions of US women are going without any form of OB-GYN coverage putting them at risk for disease. Despite the rapid growth of the US female population, obstetrician-gynecologist (OB-GYN) residency programs have decreased, and the number of first-year...